Additional info: Once the PA expires, the member must enroll in Vida and meet active monthly engagement requirements to continue coverage
The 35th Barometer from Sermo, a healthcare provider social engagement platform and provider of healthcare insights, revealed that healthcare providers are most eager to see GLP-1 medications be approved to treat sleep apnea
If youre a 73 year-old lean guy who had a heart attack and wants to use a low dose to prevent the potential of cardiovascular issues down the road, that's a different person than someone who wants to lose 30 pounds, he says
Furthermore, oral administration may improve efficacy through improved compliance and earlier initiation of treatment compared with injectables 6,7
Smaller doses tend to lead to fewer side effects, which is why doctors usually start patients on low GLP-1 doses
This is a normal and expected response to weight loss, not a side effect of the medication itself